Status:
COMPLETED
Dose Proportionality and Food Effect of Morphine Sulfate
Lead Sponsor:
Roxane Laboratories
Conditions:
Pain
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Establish the dose proportionality of the 15 mg and 30 mg morphine sulfate tablets and to examine the effect of food on absorption from the 30 mg tablet.
Eligibility Criteria
Inclusion
- No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
Exclusion
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to morphine sulfate or any comparable or similar product.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00994539
Start Date
January 1 2007
End Date
February 1 2007
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CEDRA Clinical Research
Austin, Texas, United States, 78759